PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY: Form 990, tax year 2025
View the entire original 990 at ProPublica ↗
- Organization
- PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (EIN 47-3355381)
- Tax period
- 2025-01-01 to 2025-12-31
- Filed
- 2026-08-06
- IRS object ID
- 202632189349300148
- Schema version
- 2025v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2026-08-06T13:44:10-04:00 | ReturnTs |
| Tax Period End | 2025-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PwC US Tax LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 655 NEW YORK AVENUE NW SUITE 1100 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20001 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2025-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 473355381 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % SARA COBLIN | InCareOfNm |
| Business Name Control | PARK | BusinessNameControlTxt |
| Phone | 4159304386 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 LETTERMAN DRIVE D3500 | AddressLine1Txt |
| City | SAN FRANCISCO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94129 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KAREN E KNUDSEN COSTELLO | PersonNm |
| Person Title | CEO | PersonTitleTxt |
| Phone | 4159304386 | PhoneNum |
| Signature | 2026-08-04 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | TRAVIS PATTON | PreparerPersonNm |
| PTIN | P00369623 | PTIN |
| Phone | 6464713000 | PhoneNum |
| Preparation | 2026-08-03 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2025 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | SEAN PARKER | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 LETTERMAN DRIVE D3500 | AddressLine1Txt |
| City | SAN FRANCISCO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94129 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $180,131,815 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.PARKERICI.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2015 | FormationYr |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Activity Or Mission | SEE SCHEDULE O | ActivityOrMissionDesc |
| Voting Members Governing Body | 15 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 14 | VotingMembersIndependentCnt |
| Total Employee | 31 | TotalEmployeeCnt |
| Total Volunteers | 20 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $44,804,456 | PYContributionsGrantsAmt |
| CY Contributions Grants | $175,140,008 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $2,800,807 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $1,240,750 | CYProgramServiceRevenueAmt |
| PY Investment Income | $16,986,942 | PYInvestmentIncomeAmt |
| CY Investment Income | $3,466,352 | CYInvestmentIncomeAmt |
| PY Other Revenue | $2,354,964 | PYOtherRevenueAmt |
| CY Other Revenue | $284,705 | CYOtherRevenueAmt |
| PY Total Revenue | $66,947,169 | PYTotalRevenueAmt |
| CY Total Revenue | $180,131,815 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $29,715,699 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $3,623,255 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $10,443,144 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $11,188,563 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $467,041 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $14,312,191 | PYOtherExpensesAmt |
| CY Other Expenses | $38,983,759 | CYOtherExpensesAmt |
| PY Total Expenses | $54,471,034 | PYTotalExpensesAmt |
| CY Total Expenses | $53,795,577 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $12,476,135 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $126,336,238 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $223,870,654 | TotalAssetsBOYAmt |
| Total Assets EOY | $285,156,429 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $38,432,216 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $8,671,312 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $185,438,438 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $276,485,117 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY'S (PICI) MISSION IS TO DEVELOP AND ACCELERATE ACCESS TO BREAKTHROUGH CANCER THERAPIES, CURATING INNOVATION FROM DISCOVERY TO PATIENT ACCESS. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $46,776,153 | ExpenseAmt |
| Grant | $3,623,255 | GrantAmt |
| Revenue | $1,240,750 | RevenueAmt |
| Desc | PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH, COLLABORATION, AND DISCOVERY, AND THE TRANSLATION OF THESE ADVANCES INTO CURES AND TREATMENTS FOR THE BENEFIT OF PATIENTS. TO DO THIS, PICI PARTNERS WITH ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS TO CONDUCT ITS DISCOVERY AND CLINICAL RESEARCH AND PROVIDES ITS PARTNERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT, CONSUMABLES, BIOINFORMATICS ANALYSIS, AND A SPECIMEN BIOBANK. PICI ALSO FUNDS AND OTHERWISE SUPPORTS CANCER IMMUNOTHERAPY RESEARCH WITHIN ITS CONSORTIUM. | Desc |
| Total Program Service Expenses | $46,776,153 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | false | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | false | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | Yes (true) | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (true) | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | Yes (true) | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 32 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 31 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 15 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 14 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (true) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | SARA COBLIN | PersonNm |
| Phone | 6288997600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 LETTERMAN DRIVE SUITE D3500 | AddressLine1Txt |
| City | SAN FRANCISCO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94129 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (26 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd |
|---|---|---|---|---|---|---|---|---|---|
| TARAK MODY | |||||||||
| CHIEF BUSINESS OFF. THRU 8/25 | 40.0 | 0.0 | Yes (X) | $791,771 | $0 | $94,692 | |||
| JOHN CONNOLLY PHD | |||||||||
| CHIEF SCIENTIFIC OFFICER | 40.0 | 0.0 | $703,149 | $0 | $75,026 | Yes (X) | |||
| KAREN E KNUDSEN COSTELLO | |||||||||
| CEO AS OF 03/2025 | 40.0 | 0.0 | $655,478 | $0 | $58,978 | Yes (X) | Yes (X) | ||
| KEVIN MARKS | |||||||||
| CHIEF LEGAL OFFICER | 40.0 | 0.0 | $623,269 | $0 | $75,194 | Yes (X) | |||
| CHRIS CABANSKI THRU 1225 | |||||||||
| SR DIR, NETWORK CLIN. RESEARCH | 40.0 | 0.0 | Yes (X) | $314,624 | $0 | $200,315 | |||
| SARA COBLIN | |||||||||
| SR VP FINANCE & ADMIN. | 40.0 | 0.0 | $444,632 | $0 | $51,918 | Yes (X) | |||
| SHANE CORCORAN | |||||||||
| SENIOR VP, STRAT. OPS. & COMMS | 40.0 | 0.0 | Yes (X) | $441,686 | $0 | $32,245 | |||
| MARKO SPASIC | |||||||||
| SR MEDICAL DIR, HEAD OF MED | 40.0 | 0.0 | Yes (X) | $398,778 | $0 | $21,808 | |||
| CHRISTEN DIPETRILLO | |||||||||
| HEAD OF INTELLECTUAL PROPERTY | 40.0 | 0.0 | Yes (X) | $330,222 | $0 | $74,541 | |||
| SEAN N PARKER | |||||||||
| CHAIR OF THE BOARD & DIRECTOR | 5.0 | 5.0 | $0 | $0 | $0 | Yes (X) | Yes (X) | ||
| MICHAEL POLANSKY | |||||||||
| EXECUTIVE VP & DIRECTOR | 5.0 | 5.0 | $0 | $0 | $0 | Yes (X) | Yes (X) | ||
| TOM VAN LOBEN SELS | |||||||||
| TREASURER & DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | Yes (X) | ||
| JEFFREY A BLUESTONE PHD | |||||||||
| VICE CHAIR & DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| TONY COLES MD | |||||||||
| DIRECTOR THRU 10/25 | 0.8 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| ERIC ESRAILIAN MD MPH | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| SCOTT GOTTLIEB MD | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| BEN HOROWITZ | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| JEFF HUBER | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| BOB HUGIN | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| REED JOBS | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| BOB NELSEN | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| BRUCE PARKER PHD | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| BOB PITTMAN | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| RAMY IBRAHIM MD | |||||||||
| DIRECTOR THRU 10/25 | 0.8 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| MARGO GEORGIADIS | |||||||||
| DIRECTOR | 1.0 | 0.0 | $0 | $0 | $0 | Yes (X) | |||
| SUSAN DAWSON | |||||||||
| SECRETARY | 5.0 | 5.0 | $0 | $0 | $0 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $4,703,609 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $684,717 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 27 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd |
|---|---|---|---|---|---|---|---|---|---|---|
| PATHEON UK LIMITED | ||||||||||
| KINGFISHER DRIVE | SWINDON | 0 | UK | SN3 5BZ | VACCINE MFG. | $2,586,957 | ||||
| STANFORD UNIVERSITY | ||||||||||
| PATENT/CLINIC EXP. | $1,232,482 | 415 BROADWAY STREET | REDWOOD CITY | CA | 94063 | |||||
| REGENTS OF THE UNIV OF CALIFORNIA | ||||||||||
| CLINICAL TRIAL EXP. | $999,585 | 1111 FRANKLIN STREET 11TH FLOOR | OAKLAND | CA | 94607 | |||||
| DANA-FARBER CANCER INSTITUTE INC | ||||||||||
| PATENT/CLINIC EXP. | $880,244 | 450 BROOKLINE AVENUE | BOSTON | MA | 02215 | |||||
| REGENTS OF UNIV OF CAL SAN FRANC | ||||||||||
| PATENT & LICENSE EXP | $656,549 | 1111 FRANKLIN STREET 11TH FLOOR | OAKLAND | CA | 94607 | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 21 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $2,491,522 | FundraisingAmt |
| All Other Contributions | $172,648,486 | AllOtherContributionsAmt |
| Total Contributions | $175,140,008 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| LICENSE FEES | 900099 | $40,750 | $40,750 |
| CONSULTING REV. | 900099 | $1,200,000 | $1,200,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $1,240,750 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,465,310 | TotalRevenueColumnAmt |
| Exclusion | $3,465,310 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $284,705 | TotalRevenueColumnAmt |
| Exclusion | $284,705 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,042 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,042 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,042 | TotalRevenueColumnAmt |
| Exclusion | $1,042 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $2,491,522 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $0 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $180,131,815 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $1,240,750 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $3,751,057 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,373,255 | TotalAmt |
| Program Services | $3,373,255 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $250,000 | TotalAmt |
| Program Services | $250,000 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,707,897 | TotalAmt |
| Program Services | $1,270,723 | ProgramServicesAmt |
| Management And General | $1,363,703 | ManagementAndGeneralAmt |
| Fundraising | $73,471 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,961,962 | TotalAmt |
| Program Services | $4,492,490 | ProgramServicesAmt |
| Management And General | $2,272,029 | ManagementAndGeneralAmt |
| Fundraising | $197,443 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $133,273 | TotalAmt |
| Program Services | $81,614 | ProgramServicesAmt |
| Management And General | $48,235 | ManagementAndGeneralAmt |
| Fundraising | $3,424 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $971,268 | TotalAmt |
| Program Services | $587,619 | ProgramServicesAmt |
| Management And General | $375,715 | ManagementAndGeneralAmt |
| Fundraising | $7,934 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $414,163 | TotalAmt |
| Program Services | $261,120 | ProgramServicesAmt |
| Management And General | $145,719 | ManagementAndGeneralAmt |
| Fundraising | $7,324 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,245,104 | TotalAmt |
| Program Services | $3,122,456 | ProgramServicesAmt |
| Management And General | $122,648 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $379,762 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $379,762 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,477,419 | TotalAmt |
| Program Services | $1,147,470 | ProgramServicesAmt |
| Management And General | $235,838 | ManagementAndGeneralAmt |
| Fundraising | $94,111 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $60,914 | TotalAmt |
| Program Services | $567 | ProgramServicesAmt |
| Management And General | $59,975 | ManagementAndGeneralAmt |
| Fundraising | $372 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $142,690 | TotalAmt |
| Program Services | $76,848 | ProgramServicesAmt |
| Management And General | $63,850 | ManagementAndGeneralAmt |
| Fundraising | $1,992 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $361,615 | TotalAmt |
| Program Services | $267,161 | ProgramServicesAmt |
| Management And General | $85,718 | ManagementAndGeneralAmt |
| Fundraising | $8,736 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,617,210 | TotalAmt |
| Program Services | $921,810 | ProgramServicesAmt |
| Management And General | $663,056 | ManagementAndGeneralAmt |
| Fundraising | $32,344 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $804,068 | TotalAmt |
| Program Services | $610,010 | ProgramServicesAmt |
| Management And General | $185,086 | ManagementAndGeneralAmt |
| Fundraising | $8,972 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,550,707 | TotalAmt |
| Program Services | $3,544,219 | ProgramServicesAmt |
| Management And General | $4,600 | ManagementAndGeneralAmt |
| Fundraising | $1,888 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $165,194 | TotalAmt |
| Program Services | $7,223 | ProgramServicesAmt |
| Management And General | $157,971 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| COLLABORATIVE RESEARCH PROG. | $21,015,152 | $21,015,152 | $0 | $0 |
| PATENT & LICENSE EXPENSE | $4,125,033 | $4,125,033 | $0 | $0 |
| INSTITUTION STAFF SUPPORT | $1,423,770 | $1,423,770 | $0 | $0 |
| RECRUITING | $304,324 | $0 | $304,324 | $0 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $310,797 | TotalAmt |
| Program Services | $197,613 | ProgramServicesAmt |
| Management And General | $84,154 | ManagementAndGeneralAmt |
| Fundraising | $29,030 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $53,795,577 | TotalAmt |
| Program Services | $46,776,153 | ProgramServicesAmt |
| Management And General | $6,552,383 | ManagementAndGeneralAmt |
| Fundraising | $467,041 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $682,163 | BOYAmt |
| EOY | $552,055 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $27,944,828 | BOYAmt |
| EOY | $37,003,694 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,956,768 | BOYAmt |
| EOY | $26,854,850 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $713,816 | BOYAmt |
| EOY | $662,829 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $400,000 | BOYAmt |
| EOY | $418,530 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,610,092 | BOYAmt |
| EOY | $2,958,586 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $7,901,030 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $7,901,030 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $295,000 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $51,705,196 | BOYAmt |
| EOY | $54,432,280 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $136,078,266 | BOYAmt |
| EOY | $161,974,562 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,484,525 | BOYAmt |
| EOY | $299,043 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $223,870,654 | BOYAmt |
| EOY | $285,156,429 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,876,148 | BOYAmt |
| EOY | $8,351,742 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $30,556,068 | BOYAmt |
| EOY | $319,570 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,432,216 | BOYAmt |
| EOY | $8,671,312 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $174,101,042 | BOYAmt |
| EOY | $243,998,841 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,337,396 | BOYAmt |
| EOY | $32,486,276 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $185,438,438 | BOYAmt |
| EOY | $276,485,117 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $223,870,654 | BOYAmt |
| EOY | $285,156,429 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $126,336,238 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$8,576,420 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$26,713,139 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp (17 entries)
| CityCityNm | State AbbreviationStateAbbreviationCd | CountryCountryCd |
|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | ||
| NEW YORK | NY | |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | ||
| HOUSTON | TX | |
| UNIVERSITY OF CALIFORNIA LOS ANGELES | ||
| LOS ANGELES | CA | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | ||
| SAN FRANCISCO | CA | |
| UNIVERSITY OF PENNSYLVANIA | ||
| PHILADELPHIA | PA | |
| DANA-FARBER CANCER INSTITUTE | ||
| BOSTON | MA | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | ||
| NEW YORK | NY | |
| FRED HUTCHINSON CANCER RESEARCH CENTER | ||
| ST LOUIS | MO | |
| WEILL CORNELL MEDICINE | ||
| NEW YORK | NY | |
| BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE | ||
| DUARTE | CA | |
| WASHINGTON UNIVERSITY IN ST LOUIS | ||
| ST LOUIS | MO | |
| CHILDREN'S HOSPITAL OF PHILADELPHIA | ||
| PHILADELPHIA | PA | |
| UNIVERSITY OF PITTSBURGH | ||
| PITTSBURGH | PA | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | ||
| LOS ANGELES | CA | |
| STANFORD MEDICINE | ||
| STANFORD | CA | |
| UNIVERSITAT BASEL | ||
| BASEL | SZ | |
| MASSACHUSETTS GENERAL HOSPITAL | ||
| BOSTON | MA | |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| CY Minus3 Yr Endwmt Fund | CYMinus3YrEndwmtFundGrp | |
| CY Minus4 Yr Endwmt Fund | CYMinus4YrEndwmtFundGrp | |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $720,271 | OtherCostOrOtherBasisAmt |
| Depreciation | $720,271 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $0 | OtherCostOrOtherBasisAmt |
| Depreciation | $0 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $7,180,759 | OtherCostOrOtherBasisAmt |
| Depreciation | $7,180,759 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $0 | TotalBookValueLandBuildingsAmt |
| Financial Derivatives | FinancialDerivativesGrp | |
| Closely Held Equity Interests | CloselyHeldEquityInterestsGrp |
Other Securities OtherSecuritiesGrp (6 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| ARSENAL BIOSCIENCES | $25,001,565 | F |
| 3T BIOSCINECES | $1,215,654 | F |
| GEORGIAMUNE INC. | $23,423,447 | F |
| APRICITY HEALTH, LLC | $232,280 | F |
| SENTI BIOSCIENCES, INC. | $26,000 | F |
| XAIRA THERAPEUTICS | $4,533,334 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $54,432,280 | TotalBookValueSecuritiesAmt |
Invst Program Related Org InvstProgramRelatedOrgGrp (9 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| IMAGINAB | $1,004,281 | F |
| DISPATCH BIO | $57,245,163 | F |
| MOONLIGHT BIO | $15,582,384 | F |
| AKAMIS | $626,106 | F |
| LYELL IMMUNOPHARMA,INC | $11,211,245 | F |
| TWAIN | $5,000,000 | F |
| ARSENAL BIOSCIENCES | $53,619,294 | F |
| 3T BIOSCIENCES | $14,376,541 | F |
| KIIK THERAPEUTICS | $3,309,548 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Program Rltd | $161,974,562 | TotalBookValueProgramRltdAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | LEASE LIABILITY | Desc |
| Amt | $319,570 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $319,570 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $144,842,256 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$8,576,420 | NetUnrealizedGainsInvstAmt |
| Other Revenue | -$26,713,139 | OtherRevenueAmt |
| Revenue Not Reported | -$35,289,559 | RevenueNotReportedAmt |
| Revenue Subtotal | $180,131,815 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $180,131,815 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $53,795,577 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Subtotal | $53,795,577 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $53,795,577 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART X, LINE 2: | THE ORGANIZATION, A CALIFORNIA NOT-FOR-PROFIT CORPORATION, IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC) AND SECTION 23701D OF THE CALIFORNIA REVENUE AND TAXATION CODE, EXCEPT TO THE EXTENT OF UNRELATED BUSINESS INCOME UNDER IRC SECTIONS 511 THROUGH 515. UNRELATED BUSINESS INCOME TAX, IF ANY, IS IMMATERIAL. AS OF DECEMBER 31, 2025 AND 2024, THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL. THE ORGANIZATION MAY BE SUBJECT TO ROUTINE AUDIT BY THE INTERNAL REVENUE SERVICE (IRS); HOWEVER, THERE ARE CURRENTLY NO AUDITS FOR ANY TAX PERIODS IN PROGRESS. THE ORGANIZATION HAS NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES AS OF DECEMBER 31, 2025 AND 2024. |
| Part XI, LINE 2D: | INVESTMENT WRITE OFF $ (26,713,139) |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | 0 | 1 | Program Services | SERVICES&SPONSORSHIPS | $15,680 |
| Europe (Including Iceland and Greenland) | 0 | 0 | Grantmaking | $250,000 | |
| East Asia and the Pacific | 0 | 0 | Program Services | RESEARCH | $88,800 |
| Europe (Including Iceland and Greenland) | 0 | 1 | Program Services | VACCINE MANUFACTURING | $2,586,957 |
| Europe (Including Iceland and Greenland) | 0 | 0 | Investments | $626,106 | |
| East Asia and the Pacific | 0 | 0 | Investments | $5,000,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 2 | SubtotalEmployeesCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 2 | TotalEmployeeCnt |
| Subtotal Spent | $8,567,543 | SubtotalSpentAmt |
| Total Spent | $8,567,543 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | Europe (Including Iceland and Greenland) | RegionTxt |
| Purpose Of Grant | PROGRAM SUPPORT | PurposeOfGrantTxt |
| Cash Grant | $250,000 | CashGrantAmt |
| Manner Of Cash Disbursement | ACH TRANSFER | MannerOfCashDisbursementTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 0 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2 | PICI AWARDS GRANTS SUBJECT TO A MASTER COLLABORATION AGREEMENT AND A SPECIFIC GRANT AGREEMENT SUBJECT TO EACH INSTITUTION. EACH INSTITUTION SUBMITS PROJECT PROPOSALS WHICH ARE EVALUATED TO ENSURE THEY ARE WITHIN THE CHARITABLE MISSION BEFORE APPROVAL. ALSO, EACH INSTITUTION AND GRANT RECIPIENT MUST PROVIDE PICI WITH ANNUAL REPORTS OF PROJECT PROGRESS AND ASSOCIATED SPEND. |
| PART I, LINE 3, NUMBERS (5) AND (6) | EACH OF THESE INVESTMENTS ARE PROGRAM-RELATED INVESTMENTS OF PICI. PICI INVESTS IN COMPANIES TO ACCELERATE FACILITATING THE DEVELOPMENT OF NOVEL CANCER THERAPIES. EACH INVESTMENT COMPANY MUST PROVIDE QUARTERLY FINANCIALS AND PICI IS REPRESENTED ON THE BOARD OF DIRECTORS FOR ONE OF THE INVESTMENTS. RESEARCH SPONSORSHIP WAS ALIGNED WITH THE COMPANY MISSION AND THE REMAINING IMMATERIAL SPEND WAS WITH VENDORS TO SUPPORT CLINICAL TRIALS AND EMPLOYEE DEVELOPMENT. |
| PART I, LINE 3 | ACCRUAL BASIS |
Schedule G IRS990ScheduleG
Fundraiser Activity Info FundraiserActivityInfoGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | WSCOLLABORATIVE | PersonNm |
| Activity | CONSULTING | ActivityTxt |
| Fundraiser Control Of Funds | false | FundraiserControlOfFundsInd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | PARTY | Event1Nm |
| Gross Receipts Event1 | $2,491,522 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $2,491,522 | CharitableContriEvent1Amt |
| Other Events Total | 0 | OtherEventsTotalCnt |
| Gross Receipts Total | $2,491,522 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $2,491,522 | CharitableContributionsTotAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (11 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| CONQUER CANCER FOUNDATION | |||||||
| 2318 MILL ROAD | ALEXANDRIA | VA | 22314 | 311667995 | 501(C)(3) | $1,000,000 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| DANA-FARBER CANCER INSTITUTE INC | |||||||
| 450 BROOKLINE AVENUE | BOSTON | MA | 21115 | 042263040 | 501(C)(3) | $178,420 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| MEMORIAL SLOAN KETTERING CANCER CENTER | |||||||
| 1275 YORK AVE BOX 69 | NEW YORK | NY | 10065 | 912154267 | 501(C)(3) | $167,500 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| STANFORD UNIVERSITY | |||||||
| 3145 PORTER DRIVE | PALO ALTO | CA | 94304 | 941156365 | 501(C)(3) | $820,714 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| THE J DAVID GLADSTONE INSTITUTES | |||||||
| 1650 OWENS STREET | SAN FRANCISCO | CA | 94158 | 237203666 | 501(C)(3) | $175,000 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 10920 WILSHIRE BLVD | LOS ANGELES | CA | 90024 | 956006143 | GOVT | $133,886 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN | |||||||
| 333 CALIFORNIA ST | SAN FRANCISCO | CA | 94143 | 946036493 | GOVT | $191,308 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| 3451 WALNUT STREET ROOM 310 | PHILADELPHIA | PA | 19104 | 231352685 | 501(C)(3) | $254,161 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | |||||||
| 1400 PRESSLER STREET | HOUSTON | TX | 77030 | 746001118 | 501(C)(3) | $127,267 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| UNIVERSITY OF PITTSBURGH | |||||||
| 420 FIFTH AVENUE | PITTSBURGH | PA | 15260 | 260965591 | 501(C)(3) | $249,999 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| WEILL CORNELL MEDICINE | |||||||
| 1300 YORK AVENUE | NEW YORK | NY | 10065 | 131623978 | 501(C)(3) | $75,000 | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 11 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PICI AWARDS GRANTS SUBJECT TO A MAIN COLLABORATION AGREEMENT AND A SPECIFIC GRANT AGREEMENT SUBJECT TO EACH INSTITUTION. PICI AND EACH INSTITUTION JOINTLY REVIEW AND APPROVE PROJECT PROPOSALS TO ENSURE THEY HAVE A LEGITIMATE RESEARCH PURPOSE AND ARE WITHIN THE CHARITABLE MISSION BEFORE APPROVAL. ALSO, EACH INSTITUTION AND GRANT RECIPIENT MUST PROVIDE PICI WITH ANNUAL REPORTS OF PROJECT PROGRESS AND ASSOCIATED SPEND. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JOHN CONNOLLY PHD | ||||||||||||||
| CHIEF SCIENTIFIC OFFICER | $624,119 | $0 | $0 | $0 | $79,030 | $0 | $10,500 | $0 | $64,526 | $0 | $778,175 | $0 | $0 | $0 |
| KEVIN MARKS | ||||||||||||||
| CHIEF LEGAL OFFICER | $622,099 | $0 | $0 | $0 | $1,170 | $0 | $10,500 | $0 | $64,694 | $0 | $698,463 | $0 | $0 | $0 |
| SHANE CORCORAN | ||||||||||||||
| SENIOR VP, STRAT. OPS. & COMMS | $440,516 | $0 | $0 | $0 | $1,170 | $0 | $10,500 | $0 | $21,745 | $0 | $473,931 | $0 | $0 | $0 |
| TARAK MODY | ||||||||||||||
| CHIEF BUSINESS OFF. THRU 8/25 | $391,895 | $0 | $0 | $0 | $399,876 | $0 | $30,854 | $0 | $63,838 | $886,463 | $0 | $0 | $0 | |
| SARA COBLIN | ||||||||||||||
| SR VP FINANCE & ADMIN. | $443,462 | $0 | $0 | $0 | $1,170 | $0 | $10,500 | $0 | $41,418 | $0 | $496,550 | $0 | $0 | $0 |
| MARKO SPASIC | ||||||||||||||
| SR MEDICAL DIR, HEAD OF MED | $397,608 | $0 | $0 | $0 | $1,170 | $0 | $0 | $0 | $21,808 | $0 | $420,586 | $0 | $0 | $0 |
| CHRISTEN DIPETRILLO | ||||||||||||||
| HEAD OF INTELLECTUAL PROPERTY | $329,052 | $0 | $0 | $0 | $1,170 | $0 | $9,856 | $0 | $64,685 | $0 | $404,763 | $0 | $0 | $0 |
| KAREN E KNUDSEN COSTELLO | ||||||||||||||
| CEO AS OF 03/2025 | $604,600 | $0 | $50,000 | $0 | $878 | $0 | $10,500 | $0 | $48,478 | $0 | $714,456 | $0 | $0 | $0 |
| CHRIS CABANSKI THRU 1225 | ||||||||||||||
| SR DIR, NETWORK CLIN. RESEARCH | $313,483 | $0 | $0 | $0 | $1,141 | $0 | $155,308 | $0 | $45,007 | $0 | $514,939 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A | ANYONE TRAVELING OVER 3000 MILES CAN FLY BUSINESS CLASS OR FIRST CLASS (IF ONLY 2 LEVELS OF SERVICE ARE OFFERED). VP'S CAN TRAVEL BUSINESS OR FIRST CLASS FOR TRAVEL OVER 2000 MILES. |
| PART I, LINE 3 | THE ORGANIZATION FOLLOWS THE PROCESS SET FORTH IN ITS BYLAWS TO REVIEW AND APPROVE THE TOTAL COMPENSATION OF ITS CHIEF EXECUTIVE OFFICER, INCLUDING SALARY, BONUS, AND BENEFITS. THE BYLAWS REQUIRE THE BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE TO REVIEW ANY COMPENSATION PACKAGES, AND TO APPROVE SUCH COMPENSATION ONLY AFTER DETERMINING THAT THE COMPENSATION IS JUST AND REASONABLE. THIS REVIEW AND APPROVAL OCCURS WHEN THE CHIEF EXECUTIVE OFFICER IS HIRED, WHEN THE TERM OF EMPLOYMENT OF SUCH OFFICER IS RENEWED OR EXTENDED, AND WHEN THE COMPENSATION OF SUCH OFFICER IS MODIFIED, UNLESS THE MODIFICATION APPLIES TO SUBSTANTIALLY ALL OF THE EMPLOYEES OF THE ORGANIZATION. |
| PART I, LINE 4A | TARAK MODY RECEIVED A SEVERANCE IN THE AMOUNT OF $399,096. |
| PART I, LINE 7 | MOST OF PICI'S EMPLOYMENT AGREEMENTS, WHICH ARE NEGOTIATED AT ARMS-LENGTH WITH REFERENCE TO COMPARABILITY DATA, CONTAIN A PROVISION PERMITTING ANNUAL INCENTIVE BONUSES, WHICH ARE CAPPED AT UP TO A FIXED PERCENTAGE. |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JOHN CONNOLLY PHD | PersonNm |
| Relationship With Org | EMPLOYEE | RelationshipWithOrgTxt |
| Loan Purpose | HOME LOAN | LoanPurposeTxt |
| Loan From Organization | Yes (X) | LoanFromOrganizationInd |
| Original Principal | $750,000 | OriginalPrincipalAmt |
| Balance Due | $662,829 | BalanceDueAmt |
| Default | false | DefaultInd |
| Board Or Committee Approval | Yes (true) | BoardOrCommitteeApprovalInd |
| Written Agreement | Yes (true) | WrittenAgreementInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $662,829 | TotalBalanceDueAmt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (11 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, LINE 1 | DESCRIPTION OF ORGANIZATION MISSION: THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) IS A SAN FRANCISCO-BASED NONPROFIT WHICH HAS ESTABLISHED COLLABORATION BETWEEN THE COUNTRY'S LEADING IMMUNOTHERAPY RESEARCHERS AND CANCER CENTERS, INCLUDING STANFORD UNIVERSITY; THE UNIVERSITY OF CALIFORNIA, LOS ANGELES; THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO; THE UNIVERSITY OF PENNSYLVANIA; DANA FARBER CANCER INSTITUTE; AND GLADSTONE INSTITUTES. PICI ALSO SUPPORTS TOP RESEARCHERS AT OTHER INSTITUTIONS, INCLUDING CITY OF HOPE; FRED HUTCHINSON CANCER RESEARCH CENTER; ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI; INSTITUTE FOR SYSTEMS BIOLOGY; MEMORIAL SLOAN KETTERING CANCER CENTER; THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER; WEILL CORNELL MEDICAL COLLEGE; CHILDREN'S HOSPITAL OF PHILADELPHIA, UNIVERSITY OF PITTSBURGH, UNIVERSITY OF SOUTHERN CALIFORNIA (LA), UNIVERSITAT BASEL, MASSACHUSETTS GENERAL, AND WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS. BY FORGING ALLIANCES WITH ACADEMIC, INDUSTRY, AND NONPROFIT PARTNERS PICI SUPPORTS NOVEL RESEARCH TO FULFILL ITS MISSION: TO ACCELERATE THE DEVELOPMENT OF BREAKTHROUGH IMMUNE THERAPIES TO TRANSFORM ALL CANCERS INTO CURABLE DISEASES. |
| FORM 990, PART VI, SECTION A, LINE 1 | THE BOARD OF DIRECTORS IS COMPRISED OF ONE 'CLASS A' DIRECTOR WITH THE BALANCE OF THE DIRECTORS SERVING AS 'CLASS B' DIRECTORS. THE CLASS A DIRECTOR MUST BE PRESENT TO CONSTITUTE A QUORUM, UNLESS THE CLASS A DIRECTOR'S RECUSAL IS REQUIRED BY LAW OR CORPORATE POLICY. EACH DIRECTOR IS ENTITLED TO ONE VOTE. ANY ACT OF THE BOARD OF DIRECTORS REQUIRES THE AFFIRMATIVE VOTE OF BOTH THE CLASS A DIRECTOR AND A MAJORITY OF THE CLASS B DIRECTORS PRESENT AT A MEETING AT WHICH A QUORUM IS PRESENT, EXCEPT AS OTHERWISE PROVIDED IN THE BYLAWS. PICI DOES HAVE AN EXECUTIVE COMMITTEE. IT HAS ALL THE AUTHORITY OF THE BOARD OF DIRECTORS BETWEEN REGULAR AND SPECIAL MEETINGS, EXCEPT AS OTHERWISE PROVIDED IN THE BYLAWS OR BY THE BOARD OF DIRECTORS IN SPECIFIC INSTANCES. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO AND REVIEWED BY THE BOARD OF DIRECTORS AT ITS NEXT REGULARLY SCHEDULED MEETING. |
| FORM 990, PART VI, SECTION A, LINE 2 | THE FOLLOWING DIRECTORS, KEY EMPLOYEES, AND OFFICERS HAVE A BUSINESS RELATIONSHIP AND/OR FAMILY RELATIONSHIP: JOHN CONNOLLY, SUSAN DAWSON, ERIC ESRAILIAN, SCOTT GOTTLIEB, BEN HOROWITZ, JEFF HUBER, REED JOBS, BOB NELSEN, BRUCE PARKER, SEAN PARKER, BOB PITTMAN, MICHAEL POLANSKY, TOM VAN LOBEN SELS, KAREN E. KNUDSEN (COSTELLO). |
| FORM 990, PART VI, SECTION A, LINE 7A | THE DESIGNATOR HAS THE AUTHORITY TO APPOINT MEMBERS OF PICI'S GOVERNING BODY. |
| FORM 990, PART VI, SECTION A, LINE 7B | THE DESIGNATOR HAS THE AUTHORITY TO REMOVE MEMBERS OF PICI'S GOVERNING BODY, TO CONSENT TO SUCH REMOVAL BY THE BOARD, AND TO CONSENT TO ANY AMENDMENTS TO PICI'S BYLAWS. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE. A COMPLETE COPY OF THE FORM 990 AND SUPPORTING SCHEDULES WAS PROVIDED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE BOARD AUTHORIZES AND OVERSEES A REVIEW OF THE ADMINISTRATION OF THE CONFLICT OF INTEREST POLICY. THE REVIEW CONSIDERS THE LEVEL OF COMPLIANCE WITH THE POLICY, THE CONTINUING SUITABILITY OF THE POLICY, AND WHETHER THE POLICY SHOULD BE MODIFIED AND IMPROVED. IF A TRANSACTION ARISES WHERE THERE IS A CONFLICT OF INTEREST, THE PERSON WITH SUCH CONFLICT IS NOT ALLOWED TO VOTE ON THE TRANSACTION NOR BE PRESENT FOR SUCH VOTE. THE CONFLICT OF INTEREST POLICY COVERS EACH DIRECTOR, CORPORATE OFFICER, TOP MANAGEMENT OFFICIAL, TOP FINANCIAL OFFICIAL AND EACH KEY EMPLOYEE OF PICI, AND OTHERS THAT PICI MAY IDENTIFY. |
| FORM 990, PART VI, SECTION B, LINE 15A | THE ORGANIZATION FOLLOWS THE PROCESS SET FORTH IN ITS BYLAWS TO REVIEW AND APPROVE THE TOTAL COMPENSATION OF ITS CHIEF EXECUTIVE OFFICER, INCLUDING SALARY, BONUS, AND BENEFITS. THE BYLAWS REQUIRE THE BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE TO REVIEW ANY COMPENSATION PACKAGES, AND TO APPROVE SUCH COMPENSATION ONLY AFTER DETERMINING THAT THE COMPENSATION IS JUST AND REASONABLE. THIS REVIEW AND APPROVAL OCCURS WHEN THE CHIEF EXECUTIVE OFFICER IS HIRED, WHEN THE TERM OF EMPLOYMENT OF SUCH OFFICER IS RENEWED OR EXTENDED, AND WHEN THE COMPENSATION OF SUCH OFFICER IS MODIFIED, UNLESS THE MODIFICATION APPLIES TO SUBSTANTIALLY ALL OF THE EMPLOYEES OF THE ORGANIZATION. |
| FORM 990, PART VI, SECTION B, LINE 15B | THE ORGANIZATION DOES NOT COMPENSATE ITS CORPORATE OFFICERS, OTHER THAN ITS CEO, BUT ADHERES TO THE FOLLOWING PROCEDURES FOR ITS CEO AND KEY EMPLOYEES: THE BOARD OF DIRECTORS (OR DULY AUTHORIZED AND INDEPENDENT BOARD COMMITTEE) APPROVES THE SALARY OF PICI'S CEO AND KEY EMPLOYEES ONLY AFTER HAVING CONFIRMED IT IS FAIR AND REASONABLE BASED ON COMPARABILITY DATA AND COMPENSATION STUDIES SHOWING COMPENSATION PAID FOR COMPARABLE SERVICES AT SIMILARLY SITUATION ORGANIZATIONS. |
| FORM 990, PART VI, SECTION C, LINE 19 | PICI'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AS REQUIRED BY LAW. |
| FORM 990, PART XI, LINE 9: | OTHER CHANGES IN NET ASSETS OR FUND BALANCES INVESTMENT WRITE OFF $(26,713,139) ----------- (26,713,139) |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MAVERIC LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1 LETTERMAN DRIVE D3500 | AddressLine1Txt |
| City | SAN FRANCISCO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 94129 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 853467441 | EIN |
| Primary Activities | COVID-19 CLIN | PrimaryActivitiesTxt |
| Legal Domicile State | CA | LegalDomicileStateCd |
| Total Income | $0 | TotalIncomeAmt |
| End Of Year Assets | $0 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PICI | BusinessNameLine1Txt |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| SEAN N PARKER FOUNDATION | ||||||||||
| 314 LYTTON AVE | PALTO ALTO | CA | 94301 | 274389819 | NONPROFIT SUP | CA | 501(C)(3) | PF | PICI | Yes (true) |
| ECONOMIC INNOVATION GROUP INC | ||||||||||
| 616 H STREET NW SUITE 550 | WASHINGTON | DC | 20001 | 462450336 | PUBLIC INTERE | DC | 501(C)(4) | N/A | PICI | Yes (true) |
| PARATOPE INC | ||||||||||
| 1 LETTERMAN DRIVE SUITE D3500 | SAN FRANCISCO | CA | 94129 | 992858074 | SOCIAL WELFAR | CA | 501(C)(4) | N/A | PICI | Yes (true) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp
Other Organization Name OtherOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | SEAN N PARKER FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transaction Type | R | TransactionTypeTxt |
| Involved | $29,000,000 | InvolvedAmt |
| Method Of Amount Determination | BOOK VALUE | MethodOfAmountDeterminationTxt |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, IDENTIFICATION OF DISREGARDED ENTITIES: | NAME OF DISREGARDED ENTITY: MAVERIC, LLC ADDRESS: 1 LETTERMAN DRIVE, D3500 SAN FRANCISCO, CA 94129 EIN: 85-3467441 PRIMARY ACTIVITY: COVID-19 CLINICAL TRIAL MANAGEMENT (CURRENTLY INACTIVE) DIRECT CONTROLLING ENTITY: PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY |
| PART V, LINE 2 | THE SEAN N. PARKER FOUNDATION MADE A RECOVERABLE GRANT IN 2021. THE RECOVERABLE GRANT WAS FULLY REPAID IN 2025. |
| SCHEDULE R, SUPPLEMENTAL INFORMATION: | THE CLASS A DIRECTOR ALSO HAS A CONTROLLING INTEREST IN SEVERAL PASSIVE INVESTMENT VEHICLES. THESE INVESTMENT VEHICLES AND THE TAX-EXEMPT ENTITIES DISCLOSED UNDER PART II ABOVE MAY TECHNICALLY BE CONSIDERED "RELATED ORGANIZATIONS" OF PICI FOR IRS FORM 990 REPORTING PURPOSES THROUGH THEIR RELATIONSHIP WITH THE CLASS A DIRECTOR. THE PASSIVE INVESTMENT VEHICLES HAVE NO TRANSACTIONS OR BUSINESS RELATIONSHIPS WITH PICI AND ARE NOT DISCLOSED ON SCHEDULE R. |
Comments